rs1232203

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_019040.5(ELP4):​c.928-3081G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.237 in 151,452 control chromosomes in the GnomAD database, including 4,786 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.24 ( 4786 hom., cov: 32)

Consequence

ELP4
NM_019040.5 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.551

Publications

1 publications found
Variant links:
Genes affected
ELP4 (HGNC:1171): (elongator acetyltransferase complex subunit 4) This gene encodes a component of the six subunit elongator complex, a histone acetyltransferase complex that associates directly with RNA polymerase II during transcriptional elongation. The human gene can partially complement sensitivity phenotypes of yeast ELP4 deletion mutants. This gene has also been associated with Rolandic epilepsy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Dec 2013]
ELP4 Gene-Disease associations (from GenCC):
  • aniridia 2
    Inheritance: AD Classification: STRONG, LIMITED Submitted by: G2P, Genomics England PanelApp
  • ocular dysgenesis caused by defects in PAX6 regulation
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen
  • aniridia 1
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_019040.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.299 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_019040.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP4
NM_019040.5
MANE Select
c.928-3081G>T
intron
N/ANP_061913.3
ELP4
NM_001288726.2
c.928-3081G>T
intron
N/ANP_001275655.1G5E9D4
ELP4
NM_001288725.2
c.931-3081G>T
intron
N/ANP_001275654.1Q96EB1-3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP4
ENST00000640961.2
TSL:1 MANE Select
c.928-3081G>T
intron
N/AENSP00000492152.1Q96EB1-1
ELP4
ENST00000395934.2
TSL:1
c.928-3081G>T
intron
N/AENSP00000379267.2G5E9D4
ELP4
ENST00000379163.10
TSL:2
c.931-3081G>T
intron
N/AENSP00000368461.5Q96EB1-3

Frequencies

GnomAD3 genomes
AF:
0.237
AC:
35870
AN:
151334
Hom.:
4786
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.129
Gnomad AMI
AF:
0.519
Gnomad AMR
AF:
0.238
Gnomad ASJ
AF:
0.309
Gnomad EAS
AF:
0.0370
Gnomad SAS
AF:
0.203
Gnomad FIN
AF:
0.302
Gnomad MID
AF:
0.277
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.235
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.237
AC:
35864
AN:
151452
Hom.:
4786
Cov.:
32
AF XY:
0.235
AC XY:
17373
AN XY:
73934
show subpopulations
African (AFR)
AF:
0.129
AC:
5344
AN:
41374
American (AMR)
AF:
0.238
AC:
3600
AN:
15134
Ashkenazi Jewish (ASJ)
AF:
0.309
AC:
1072
AN:
3464
East Asian (EAS)
AF:
0.0370
AC:
190
AN:
5130
South Asian (SAS)
AF:
0.203
AC:
979
AN:
4816
European-Finnish (FIN)
AF:
0.302
AC:
3167
AN:
10496
Middle Eastern (MID)
AF:
0.278
AC:
80
AN:
288
European-Non Finnish (NFE)
AF:
0.302
AC:
20474
AN:
67740
Other (OTH)
AF:
0.231
AC:
486
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1374
2749
4123
5498
6872
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
368
736
1104
1472
1840
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.258
Hom.:
876
Bravo
AF:
0.227
Asia WGS
AF:
0.106
AC:
366
AN:
3462

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.050
DANN
Benign
0.34
PhyloP100
-0.55
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1232203;
hg19: chr11-31666208;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.